中药干预"双心疾病"临床研究进展OACSTPCD
Clinical Research Progress in TCM Intervention in "Psycho-cardiological Disease"
近年来,随着社会压力增加,"双心疾病"的患病率逐渐上升.西医以常规心血管药物联合抗抑郁或焦虑药物治疗为主.中医药具有多途径、多靶点、多机制、整体化和低毒性等特点,在干预"双心疾病"方面具有独特优势且临床疗效显著.但目前对本病的病机认识、临床诊断、辨证分型与治疗方法不尽相同.本文归纳相关文献,从中医角度综述"双心疾病"的病因病机、辨证治疗经验、临床研究情况等,以期为"双心疾病"的病证诊断、精准施治和提高疗效提供参考.
In recent years,with the increase of social pressure,the incidence of"psycho-cardiological disease"increases.Western medicine mainly uses conventional cardiovascular drugs combined with antidepressant or anxiety drugs.TCM has the characteristics of multi-pathway,multi-target,multi-mechanism,integration and low toxicity.It has unique advantages in the intervention of"psycho-cardiological disease"and has significant clinical efficacy.However,the pathogenesis,clinical diagnosis,syndrome differentiation and treatment of this disease are not the same.This article summarized relevant literature and reviewed the etiology,pathogenesis,experience in syndrome differentiation and treatment,and clinical research of this disease from the perspective of TCM,in order to provide reference for diagnosis of disease,precision treatment and improvement of curative efficacy of"psycho-cardiological disease".
廉坤;李琳;宁博;胡思远;卢彦杰;胡志希
湖南中医药大学,湖南 长沙 410208陕西中医药大学,陕西 咸阳 712046
中医学
双心疾病中药临床研究辨证论治综述
psycho-cardiological diseaseTCMclinical researchsyndrome differentiation and treatmentreview
《中国中医药信息杂志》 2024 (007)
188-192 / 5
国家自然科学基金(82274412);广东省重点领域研发项目(2020B1111100001);湖南省自然科学基金(2020JJ4062、2020JJ5408)
评论